Status:
COMPLETED
Genotype-related Effects of PUFA
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Healthy
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism
Detailed Description
To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.
Eligibility Criteria
Inclusion
- Healthy adult between 18 and 40 years of age
- BMI between 18.5 and 30 kg/m2
- Sedentary to moderate physical activity habits
Exclusion
- Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes
- Actively smoking
- Suspected abuse of alcohol or illicit drugs
- Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study
- Known or suspected medical condition related to coagulation
- Subject who cannot be expected to comply with the study procedures
- Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02296385
Start Date
June 1 2012
End Date
August 1 2014
Last Update
November 20 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.